Financials
Income statement
Fiscal date | Mar 2025 | Dec 2024 | Sep 2024 | Jun 2024 |
---|---|---|---|---|
Total reported revenue | 10.4B | 10.4B | 10.9B | 10.9B |
Cost of revenue | 9.8B | 9.5B | 9.8B | 9.6B |
Gross profit | 671M | 935M | 1.1B | 1.3B |
Operating expense | ||||
Research & development | 200M | 202M | 208M | 196M |
Selling general and admin | 366M | 353M | 396M | 390M |
Other operating expenses | — | — | — | — |
Operating income | 29M | 304M | 390M | 661M |
Non operating interest income | ||||
Income | 28M | 57M | 36M | 42M |
Expense | 216M | 216M | 199M | 197M |
Other income expense | -215M | 74M | 97M | 102M |
Pretax income | -374M | 219M | 324M | 608M |
Tax provision | -84M | 254M | 84M | 150M |
Net income | -290M | -35M | 240M | 458M |
Basic EPS | -0.4 | -0.1 | 0.3 | 0.6 |
Diluted EPS | -0.4 | -0.1 | 0.3 | 0.6 |
Basic average shares | 706.9M | 704.7M | 702.3M | 703.8M |
Diluted average shares | 706.9M | 704.7M | 703.6M | 705.3M |
EBITDA | 820M | 1.2B | 1.3B | 1.5B |
Net income from continuing op. | -290M | -35M | 240M | 458M |
Minority interests | -17M | -18M | -26M | -19M |
Preferred stock dividends | 3M | 3M | 3M | 3M |